These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Prognostic significance of assay of sex hormones, their receptors and enzymes involved in estrogen synthesis and metabolism in endometrial carcinoma]. Bochkareva NV, Kondakova IV, Kolomiets LA, Muntian AB, Stukanov SL, Fomina SV. Vopr Onkol; 2007 Feb; 53(3):315-20. PubMed ID: 18198614 [Abstract] [Full Text] [Related]
3. Relative imbalances in the expression of estrogen-metabolizing enzymes in the breast tissue of women with breast carcinoma. Singh S, Chakravarti D, Edney JA, Hollins RR, Johnson PJ, West WW, Higginbotham SM, Cavalieri EL, Rogan EG. Oncol Rep; 2005 Oct; 14(4):1091-6. PubMed ID: 16142378 [Abstract] [Full Text] [Related]
4. In vitro model of mammary estrogen metabolism: structural and kinetic differences between catechol estrogens 2- and 4-hydroxyestradiol. Dawling S, Hachey DL, Roodi N, Parl FF. Chem Res Toxicol; 2004 Sep; 17(9):1258-64. PubMed ID: 15377160 [Abstract] [Full Text] [Related]
5. [Genetic polymorphism of steroidogenic enzymes and steroid receptor level in tumors of the reproductive system]. Berstein LM, Zimarina TS, Tsyrlina EV, Kovalevskiĭ AIu, Imianitov EN. Vopr Onkol; 2004 Sep; 50(2):169-73. PubMed ID: 15176218 [Abstract] [Full Text] [Related]
7. Effect of tumor necrosis factor-alpha on estrogen metabolism and endometrial cells: potential physiological and pathological relevance. Salama SA, Kamel MW, Diaz-Arrastia CR, Xu X, Veenstra TD, Salih S, Botting SK, Kumar R. J Clin Endocrinol Metab; 2009 Jan; 94(1):285-93. PubMed ID: 18957495 [Abstract] [Full Text] [Related]
8. Disturbed balance between phase I and II metabolizing enzymes in ovarian endometriosis: a source of excessive hydroxy-estrogens and ROS? Hevir N, Ribič-Pucelj M, Lanišnik Rižner T. Mol Cell Endocrinol; 2013 Mar 10; 367(1-2):74-84. PubMed ID: 23277161 [Abstract] [Full Text] [Related]
9. Disturbed expression of phase I and phase II estrogen-metabolizing enzymes in endometrial cancer: lower levels of CYP1B1 and increased expression of S-COMT. Hevir N, Sinkovec J, Rižner TL. Mol Cell Endocrinol; 2011 Jan 01; 331(1):158-67. PubMed ID: 20887769 [Abstract] [Full Text] [Related]
10. Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk. Rebbeck TR, Troxel AB, Wang Y, Walker AH, Panossian S, Gallagher S, Shatalova EG, Blanchard R, Bunin G, DeMichele A, Rubin SC, Baumgarten M, Berlin M, Schinnar R, Berlin JA, Strom BL. J Natl Cancer Inst; 2006 Sep 20; 98(18):1311-20. PubMed ID: 16985250 [Abstract] [Full Text] [Related]
11. Genetic factors in catechol estrogen metabolism in relation to the risk of endometrial cancer. Doherty JA, Weiss NS, Freeman RJ, Dightman DA, Thornton PJ, Houck JR, Voigt LF, Rossing MA, Schwartz SM, Chen C. Cancer Epidemiol Biomarkers Prev; 2005 Feb 20; 14(2):357-66. PubMed ID: 15734958 [Abstract] [Full Text] [Related]
16. Berries and ellagic acid prevent estrogen-induced mammary tumorigenesis by modulating enzymes of estrogen metabolism. Aiyer HS, Gupta RC. Cancer Prev Res (Phila); 2010 Jun 20; 3(6):727-37. PubMed ID: 20501861 [Abstract] [Full Text] [Related]
17. Cytochrome P450 1B1 and catechol-O-methyltransferase polymorphisms and endometrial cancer susceptibility. McGrath M, Hankinson SE, Arbeitman L, Colditz GA, Hunter DJ, De Vivo I. Carcinogenesis; 2004 Apr 20; 25(4):559-65. PubMed ID: 14656940 [Abstract] [Full Text] [Related]
18. Aromatase, estrogen 2-hydroxylase, and catechol-O-methyltransferase activity in isolated, cultured gonadotropic cells of mature African catfish, Clarias gariepinus (Burchell). de Leeuw R, Smit-van Dijk W, Zigterman JW, van der Loo JC, Lambert JG, Goos HJ. Gen Comp Endocrinol; 1985 Nov 20; 60(2):171-7. PubMed ID: 4065528 [Abstract] [Full Text] [Related]